| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4276908 | Urology Practice | 2016 | 8 Pages |
Abstract
Compared with competing strategies in-hospital and extended duration prophylaxis for venous thromboembolism prevention in patients at high risk undergoing major urological oncology surgery is effective to prevent venous thromboembolism and it is cost saving.
Keywords
NCCN®ACCPVTEEDPLMWHASCOQALYICERpulmonary embolusPulmonary embolismAmerican Society of Clinical OncologyUrologyCost-benefit analysisVenous thromboembolismVenous thrombosisDVTDeep vein thrombosisNational Comprehensive Cancer Network®Incremental cost-effectiveness ratioLow molecular weight heparinPrevention & controlAmerican College of Chest Physicians
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Janet E. Baack Kukreja, Helen R. Levey, Ahmed Ghazi, Hani Rashid, Guan Wu, Edward M. Messing, James G. Dolan,